ASBP
Price
$0.38
Change
+$0.02 (+5.56%)
Updated
Jul 21, 03:39 PM (EDT)
Capitalization
N/A
BRNS
Price
$2.20
Change
+$0.70 (+46.67%)
Updated
Jul 21, 03:52 PM (EDT)
Capitalization
60.41M
17 days until earnings call
Interact to see
Advertisement

ASBP vs BRNS

Header iconASBP vs BRNS Comparison
Open Charts ASBP vs BRNSBanner chart's image
Aspire Biopharma Holdings
Price$0.38
Change+$0.02 (+5.56%)
Volume$500
CapitalizationN/A
Barinthus Biotherapeutics
Price$2.20
Change+$0.70 (+46.67%)
Volume$5.43K
Capitalization60.41M
ASBP vs BRNS Comparison Chart in %
Loading...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. BRNS commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Hold and BRNS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ASBP: $0.36 vs. BRNS: $1.50)
Brand notoriety: ASBP and BRNS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 8% vs. BRNS: 25%
Market capitalization -- ASBP: $0 vs. BRNS: $60.41M
ASBP [@Biotechnology] is valued at $0. BRNS’s [@Biotechnology] market capitalization is $60.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileBRNS’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • BRNS’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 6 TA indicator(s) are bullish while BRNS’s TA Score has 6 bullish TA indicator(s).

  • ASBP’s TA Score: 6 bullish, 2 bearish.
  • BRNS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than ASBP.

Price Growth

ASBP (@Biotechnology) experienced а +8.48% price change this week, while BRNS (@Biotechnology) price change was +49.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +34.76%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS YTD gains are higher at: 23.974 vs. ASBP (-96.887).
ASBPBRNSASBP / BRNS
CapitalizationN/A60.4M-
EBITDAN/A-58.89M-
Gain YTD-96.88723.974-404%
P/E RatioN/AN/A-
RevenueN/A15M-
Total CashN/A99.1M-
Total DebtN/A11.9M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPBRNS
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
36%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
34%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
37%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 22 days ago
60%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
22%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLMGF0.650.04
+7.26%
Viscount Mining Corp
ALSSF2.600.08
+3.17%
Alsea SA
MRPMF0.03N/A
N/A
MARCO POLO MARINE LTD.
BKWAF180.00N/A
N/A
BKW AG
SKFG0.05N/A
-6.62%
STARK FOCUS GROUP INC.

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
+0.56%
SPRO - ASBP
62%
Loosely correlated
-4.44%
ALZN - ASBP
28%
Poorly correlated
-4.09%
BRNS - ASBP
28%
Poorly correlated
-2.12%
ORIC - ASBP
27%
Poorly correlated
-1.17%
EDIT - ASBP
26%
Poorly correlated
+1.10%
More

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-2.12%
NGNE - BRNS
51%
Loosely correlated
-1.15%
NRIX - BRNS
32%
Poorly correlated
-7.28%
APM - BRNS
31%
Poorly correlated
-18.27%
ASBP - BRNS
28%
Poorly correlated
+0.56%
IMNM - BRNS
26%
Poorly correlated
+1.24%
More